Factor Xa Inhibitor [EPC]

Factor Xa Inhibitor [EPC] was reported 275560 times

Drugs of the Factor Xa Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HAEMORRHAGIC ARTERIOVENOUS MALFORMATION 829 0.8866
1 CARDIOSPASM 416 0.7455
2 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 277 0.7387
3 IMMUNISATION 268 0.6175
4 PALMOPLANTAR KERATODERMA 412 0.5683
5 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1190 0.5289
6 SPIROMETRY ABNORMAL 315 0.5268
7 MITE ALLERGY 324 0.4947
8 SENSITISATION 323 0.4256
9 BASAL GANGLIA HAEMORRHAGE 346 0.4251
10 EJECTION FRACTION 236 0.4062
11 ATRIAL THROMBOSIS 821 0.3968
12 INTERNAL HAEMORRHAGE 4516 0.3948
13 PERICARDIAL HAEMORRHAGE 854 0.3901
14 LOWER GASTROINTESTINAL HAEMORRHAGE 2833 0.3828
15 THALAMUS HAEMORRHAGE 332 0.3816
16 MYCOTIC ALLERGY 315 0.3684
17 GASTROINTESTINAL POLYP HAEMORRHAGE 217 0.3587
18 ADRENAL HAEMORRHAGE 194 0.3470
19 CARDIOVERSION 470 0.3362
20 DUST ALLERGY 318 0.3242
21 GASTROINTESTINAL HAEMORRHAGE 26400 0.3156
22 UPPER GASTROINTESTINAL HAEMORRHAGE 5292 0.3143
23 BLOOD LOSS ANAEMIA 684 0.3017
24 EMBOLIC CEREBRAL INFARCTION 196 0.2956
25 HAEMORRHAGIC STROKE 2286 0.2924
26 RENAL HAEMORRHAGE 573 0.2814
27 TRAUMATIC INTRACRANIAL HAEMORRHAGE 248 0.2699
28 CEREBELLAR HAEMORRHAGE 382 0.2671
29 EMBOLIC STROKE 935 0.2653
30 ABDOMINAL WALL HAEMATOMA 501 0.2565
31 GASTRITIS HAEMORRHAGIC 380 0.2542
32 HAEMATOMA MUSCLE 304 0.2535
33 HAEMORRHOIDAL HAEMORRHAGE 1229 0.2514
34 POST PROCEDURAL HAEMATOMA 420 0.2488
35 ATRIAL TACHYCARDIA 518 0.2464
36 INTRAVENTRICULAR HAEMORRHAGE 608 0.2442
37 CARDIAC ABLATION 432 0.2416
38 WOUND HAEMORRHAGE 879 0.2374
39 HAEMORRHAGE INTRACRANIAL 3458 0.2310
40 HAEMORRHAGIC TRANSFORMATION STROKE 340 0.2256
41 CONJUNCTIVITIS ALLERGIC 334 0.2254
42 HAEMORRHAGIC ANAEMIA 950 0.2159
43 CARDIAC AMYLOIDOSIS 235 0.2134
44 CEREBRAL HAEMATOMA 698 0.2076
45 SUBCUTANEOUS HAEMATOMA 264 0.2067
46 RETROPERITONEAL HAEMORRHAGE 510 0.2065
47 SUBDURAL HAEMATOMA 2925 0.2041
48 SHOCK HAEMORRHAGIC 1644 0.2017
49 HAEMORRHAGE URINARY TRACT 509 0.1998
50 SMALL INTESTINAL HAEMORRHAGE 402 0.1994
51 TRAUMATIC HAEMATOMA 212 0.1974
52 DUODENAL ULCER HAEMORRHAGE 564 0.1969
53 PRURITUS GENITAL 464 0.1969
54 HAEMATURIA 6717 0.1960
55 SUBDURAL HAEMORRHAGE 534 0.1950
56 HAEMOTHORAX 564 0.1942
57 GASTROINTESTINAL ULCER HAEMORRHAGE 216 0.1922
58 DYSFUNCTIONAL UTERINE BLEEDING 229 0.1886
59 SUBARACHNOID HAEMORRHAGE 1903 0.1866
60 GASTRIC ULCER HAEMORRHAGE 1014 0.1828
61 RETROPERITONEAL HAEMATOMA 402 0.1817
62 OBSTRUCTIVE SLEEP APNOEA SYNDROME 260 0.1782
63 OCCULT BLOOD POSITIVE 349 0.1775
64 POLYCYSTIC OVARIES 274 0.1765
65 ISCHAEMIC STROKE 3129 0.1751
66 SPLENIC RUPTURE 285 0.1733
67 ARTERIAL HAEMORRHAGE 198 0.1732
68 CEREBRAL ARTERY EMBOLISM 211 0.1731
69 CEREBRAL HAEMORRHAGE 6118 0.1707
70 CARDIAC VENTRICULAR THROMBOSIS 214 0.1658
71 HAEMATOMA 4197 0.1618
72 VASCULAR PSEUDOANEURYSM 279 0.1601
73 URINARY BLADDER HAEMORRHAGE 337 0.1599
74 PULMONARY THROMBOSIS 1745 0.1599
75 CAROTID ARTERY OCCLUSION 582 0.1594
76 PACKED RED BLOOD CELL TRANSFUSION 210 0.1586
77 RECTAL HAEMORRHAGE 6781 0.1577
78 ATRIAL FIBRILLATION 15253 0.1565
79 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 219 0.1559
80 EXTRADURAL HAEMATOMA 205 0.1550
81 THROMBOSIS 12454 0.1546
82 LARGE INTESTINAL HAEMORRHAGE 345 0.1535
83 POST PROCEDURAL HAEMORRHAGE 1775 0.1523
84 MELAENA 3221 0.1462
85 ANTIPHOSPHOLIPID SYNDROME 233 0.1448
86 TRAUMATIC HAEMORRHAGE 271 0.1439
87 EPISTAXIS 10711 0.1430
88 PRODUCT MONITORING ERROR 205 0.1419
89 NORMOCHROMIC NORMOCYTIC ANAEMIA 426 0.1417
90 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1248 0.1410
91 INTRACARDIAC THROMBUS 430 0.1400
92 HAEMORRHAGE SUBCUTANEOUS 480 0.1352
93 AORTIC VALVE DISEASE 218 0.1352
94 EAR HAEMORRHAGE 272 0.1343
95 HAEMOPTYSIS 3706 0.1327
96 BLOOD URINE PRESENT 2488 0.1309
97 ATRIAL FLUTTER 1032 0.1292
98 HAEMORRHAGE 13483 0.1288
99 HAEMORRHAGIC DIATHESIS 457 0.1282
100 MICROCYTIC ANAEMIA 259 0.1244
101 EMBOLISM VENOUS 377 0.1242
102 DEEP VEIN THROMBOSIS 8063 0.1240
103 HYPOVOLAEMIC SHOCK 594 0.1239
104 MOUTH HAEMORRHAGE 898 0.1224
105 MUSCLE HAEMORRHAGE 491 0.1222
106 CATHETER SITE HAEMORRHAGE 305 0.1218
107 PULMONARY ALVEOLAR HAEMORRHAGE 674 0.1200
108 GINGIVAL BLEEDING 1631 0.1193
109 PRESCRIBED UNDERDOSE 2363 0.1183
110 SYSTEMIC INFECTION 196 0.1181
111 IRON DEFICIENCY ANAEMIA 1080 0.1169
112 SINUS NODE DYSFUNCTION 214 0.1167
113 CARDIAC FAILURE CHRONIC 495 0.1160
114 TENSION HEADACHE 495 0.1150
115 INFUSION SITE HAEMORRHAGE 375 0.1139
116 AORTIC VALVE STENOSIS 203 0.1137
117 CEREBRAL INFARCTION 2769 0.1132
118 PULMONARY EMBOLISM 10522 0.1106
119 PROCEDURAL HAEMORRHAGE 433 0.1106
120 CARDIAC TAMPONADE 515 0.1083
121 INTRA-ABDOMINAL HAEMORRHAGE 258 0.1082
122 CREATININE RENAL CLEARANCE DECREASED 431 0.1076
123 BRAIN NATRIURETIC PEPTIDE INCREASED 323 0.1047
124 UTERINE HAEMORRHAGE 446 0.1046
125 ECCHYMOSIS 710 0.1035
126 TRANSFUSION 1065 0.1015
127 SLEEP TERROR 426 0.1011
128 CARDIAC PACEMAKER INSERTION 600 0.1006
129 GASTRIC HAEMORRHAGE 1135 0.0985
130 TUMOUR HAEMORRHAGE 280 0.0980
131 CARDIAC VALVE DISEASE 552 0.0965
132 RESPIRATORY SYMPTOM 274 0.0962
133 COAGULOPATHY 1554 0.0932
134 CONJUNCTIVAL HAEMORRHAGE 354 0.0926
135 HAEMARTHROSIS 813 0.0906
136 BLOOD BLISTER 283 0.0905
137 DIASTOLIC DYSFUNCTION 279 0.0903
138 POSTMENOPAUSAL HAEMORRHAGE 232 0.0889
139 CEREBROVASCULAR ACCIDENT 14617 0.0862
140 PULMONARY HAEMORRHAGE 674 0.0861
141 HAEMATEMESIS 2180 0.0859
142 CEREBRAL THROMBOSIS 243 0.0857
143 TRANSIENT ISCHAEMIC ATTACK 2798 0.0828
144 ANAL HAEMORRHAGE 229 0.0817
145 VASCULITIS 946 0.0811
146 PROTHROMBIN TIME PROLONGED 485 0.0810
147 OXYGEN CONSUMPTION INCREASED 190 0.0794
148 HYPERVOLAEMIA 392 0.0792
149 INABILITY TO AFFORD MEDICATION 775 0.0780
150 CARDIAC DISORDER 7217 0.0771
151 DYSPNOEA EXERTIONAL 2899 0.0769
152 FULL BLOOD COUNT ABNORMAL 803 0.0758
153 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 306 0.0749
154 FAECES DISCOLOURED 1622 0.0747
155 DEMENTIA 2089 0.0747
156 DUODENAL ULCER 526 0.0745
157 CUTANEOUS VASCULITIS 272 0.0744
158 VENOUS THROMBOSIS 292 0.0743
159 CRANIOCEREBRAL INJURY 224 0.0739
160 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 373 0.0736
161 VASCULAR DEVICE INFECTION 334 0.0736
162 BRAIN HERNIATION 218 0.0729
163 HAEMATOCHEZIA 4019 0.0727
164 RHINITIS ALLERGIC 322 0.0723
165 INCREASED TENDENCY TO BRUISE 665 0.0722
166 BRONCHIECTASIS 481 0.0713
167 PRODUCT LABEL ISSUE 480 0.0707
168 OBSTRUCTIVE AIRWAYS DISORDER 787 0.0707
169 CEREBRAL ISCHAEMIA 360 0.0699
170 ARTERIOSCLEROSIS CORONARY ARTERY 461 0.0695
171 EMBOLISM 576 0.0693
172 DRUG PRESCRIBING ERROR 1318 0.0685
173 GASTRITIS EROSIVE 319 0.0684
174 PERIPHERAL ISCHAEMIA 271 0.0663
175 ORTHOPNOEA 211 0.0662
176 ADVERSE EVENT 6088 0.0660
177 ULCER HAEMORRHAGE 446 0.0658
178 EYE HAEMORRHAGE 874 0.0654
179 PULMONARY ARTERIAL HYPERTENSION 949 0.0654
180 MENORRHAGIA 1285 0.0654
181 FIBRIN D DIMER INCREASED 231 0.0649
182 INFUSION SITE PAIN 837 0.0649
183 CARDIAC FAILURE ACUTE 432 0.0648
184 CONTUSION 6212 0.0645
185 INFUSION SITE SWELLING 406 0.0645
186 AORTIC STENOSIS 224 0.0643
187 LARGE INTESTINE POLYP 442 0.0637
188 LEFT VENTRICULAR FAILURE 219 0.0636
189 POTENTIATING DRUG INTERACTION 213 0.0634
190 SKIN ABRASION 300 0.0634
191 INFUSION SITE ERYTHEMA 535 0.0634
192 CARDIAC FAILURE 5089 0.0633
193 ACUTE KIDNEY INJURY 9697 0.0633
194 HEMIPLEGIA 519 0.0623
195 RIGHT VENTRICULAR FAILURE 437 0.0623
196 HAEMOGLOBIN DECREASED 6337 0.0617
197 PULMONARY HYPERTENSION 1273 0.0611
198 ACUTE RESPIRATORY FAILURE 1163 0.0604
199 INTERNATIONAL NORMALISED RATIO INCREASED 1715 0.0601
200 POLYP 391 0.0597
201 SKIN LACERATION 648 0.0595
202 THROMBOPHLEBITIS 208 0.0593
203 INTERNATIONAL NORMALISED RATIO ABNORMAL 204 0.0593
204 GOUT 1064 0.0592
205 TREATMENT NONCOMPLIANCE 3234 0.0590
206 PERICARDIAL EFFUSION 1360 0.0588
207 BENIGN PROSTATIC HYPERPLASIA 302 0.0584
208 ANAEMIA 11136 0.0583
209 FACIAL PAIN 520 0.0582
210 COVID-19 PNEUMONIA 687 0.0581
211 ARTERIOSCLEROSIS 544 0.0577
212 PETECHIAE 598 0.0573
213 HEART RATE ABNORMAL 319 0.0571
214 HEAD INJURY 1806 0.0570
215 CATHETERISATION CARDIAC 249 0.0561
216 DIVERTICULUM INTESTINAL 245 0.0560
217 VENTRICULAR TACHYCARDIA 913 0.0552
218 HYPOPNOEA 191 0.0550
219 EXERCISE TOLERANCE DECREASED 315 0.0547
220 ABNORMAL LOSS OF WEIGHT 368 0.0539
221 GLOMERULAR FILTRATION RATE DECREASED 663 0.0539
222 CARDIAC FLUTTER 348 0.0538
223 IRON DEFICIENCY 239 0.0531
224 DIVERTICULUM 377 0.0530
225 HEMIPARESIS 891 0.0525
226 OBSTRUCTION 209 0.0523
227 BODY HEIGHT DECREASED 557 0.0520
228 PURPURA 459 0.0518
229 BLOOD PRESSURE SYSTOLIC DECREASED 233 0.0512
230 MITRAL VALVE INCOMPETENCE 575 0.0508
231 DIZZINESS POSTURAL 490 0.0505
232 FLUID RETENTION 2559 0.0503
233 BLOOD IRON DECREASED 593 0.0499
234 TOOTH DISORDER 1111 0.0499
235 TROPONIN INCREASED 380 0.0499
236 GASTRIC ULCER 943 0.0496
237 ARRHYTHMIA 2344 0.0494
238 LEFT VENTRICULAR DYSFUNCTION 331 0.0494
239 INTENTIONAL PRODUCT USE ISSUE 4320 0.0493
240 BLOOD DISORDER 395 0.0493
241 VARICOSE VEIN 251 0.0485
242 HYDROCEPHALUS 260 0.0477
243 FALL 15850 0.0476
244 NEPHROGENIC ANAEMIA 219 0.0472
245 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 802 0.0472
246 HYPOACUSIS 2026 0.0470
247 TRICUSPID VALVE INCOMPETENCE 373 0.0469
248 STENT PLACEMENT 376 0.0466
249 HOSPITALISATION 7143 0.0464
250 SEASONAL ALLERGY 656 0.0463
251 RENAL IMPAIRMENT 3892 0.0463
252 HOSPICE CARE 455 0.0460
253 SLEEP APNOEA SYNDROME 878 0.0460
254 PERIPHERAL SWELLING 7061 0.0458
255 ANEURYSM 228 0.0458
256 VAGINAL HAEMORRHAGE 1986 0.0457
257 DRUG INTERACTION 7249 0.0456
258 HEART RATE IRREGULAR 1028 0.0454
259 SKIN HAEMORRHAGE 667 0.0450
260 CARDIAC FAILURE CONGESTIVE 3601 0.0448
261 CARDIOGENIC SHOCK 640 0.0446
262 RALES 259 0.0446
263 BLOOD TEST ABNORMAL 625 0.0444
264 WEIGHT FLUCTUATION 464 0.0443
265 HAEMOGLOBIN ABNORMAL 285 0.0443
266 ATRIOVENTRICULAR BLOCK 342 0.0442
267 VEIN DISORDER 220 0.0439
268 ERYSIPELAS 219 0.0435
269 ORTHOSTATIC HYPOTENSION 756 0.0434
270 INTESTINAL ISCHAEMIA 239 0.0434
271 PRODUCTIVE COUGH 2056 0.0430
272 LIMB INJURY 1163 0.0428
273 OXYGEN SATURATION DECREASED 2402 0.0427
274 PRODUCT PRESCRIBING ERROR 1017 0.0427
275 BLOOD PRESSURE DIASTOLIC DECREASED 314 0.0425
276 PHLEBITIS 216 0.0421
277 CARDIAC OPERATION 361 0.0420
278 HAEMORRHOIDS 817 0.0418
279 UROSEPSIS 386 0.0418
280 CHROMATURIA 939 0.0416
281 BRADYCARDIA 2205 0.0415
282 RETINAL HAEMORRHAGE 296 0.0415
283 LACERATION 390 0.0414
284 RENAL DISORDER 1929 0.0414
285 MACULAR DEGENERATION 494 0.0413
286 ARTHROPATHY 2292 0.0412
287 PROSTATIC DISORDER 227 0.0411
288 NEUROLOGICAL SYMPTOM 234 0.0409
289 ENDOCARDITIS 207 0.0403
290 HYPOXIA 1421 0.0403
291 AORTIC ANEURYSM 306 0.0402
292 MULTIPLE ALLERGIES 315 0.0401
293 HIP FRACTURE 1281 0.0398
294 ACUTE MYOCARDIAL INFARCTION 1174 0.0398
295 CARPAL TUNNEL SYNDROME 555 0.0396
296 HYPOMAGNESAEMIA 551 0.0395
297 COLON CANCER 587 0.0394
298 CARDIAC MURMUR 340 0.0393
299 HYPOTENSION 7863 0.0392
300 OEDEMA PERIPHERAL 4757 0.0390
301 CORONARY ARTERY STENOSIS 195 0.0387
302 FLUID OVERLOAD 564 0.0387
303 NEOPLASM MALIGNANT 2579 0.0386
304 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2016 0.0386
305 CONTRAINDICATED PRODUCT ADMINISTERED 1168 0.0385
306 FULL BLOOD COUNT DECREASED 774 0.0384
307 PERICARDITIS 645 0.0384
308 PULMONARY OEDEMA 1719 0.0383
309 INFARCTION 262 0.0382
310 HYPERKALAEMIA 1341 0.0382
311 HAEMATOCRIT DECREASED 758 0.0382
312 NEPHROPATHY 354 0.0379
313 HEART RATE DECREASED 1330 0.0378
314 NODULE 494 0.0378
315 BLOOD PRESSURE ABNORMAL 751 0.0377
316 PLEURAL EFFUSION 2294 0.0377
317 SYNCOPE 3763 0.0376
318 EJECTION FRACTION DECREASED 580 0.0373
319 COLITIS ISCHAEMIC 251 0.0372
320 SKIN NECROSIS 191 0.0368
321 LYMPHOEDEMA 254 0.0367
322 PAIN IN JAW 1032 0.0364
323 DIPLOPIA 946 0.0364
324 PELVIC FRACTURE 282 0.0362
325 DEATH 31170 0.0361
326 ANOSMIA 523 0.0361
327 ELECTROLYTE IMBALANCE 418 0.0359
328 ACUTE CORONARY SYNDROME 297 0.0358
329 DYSPNOEA 20217 0.0357
330 BLOOD MAGNESIUM DECREASED 307 0.0355
331 FACIAL PARALYSIS 303 0.0355
332 WHEEZING 2103 0.0354
333 HIATUS HERNIA 458 0.0353
334 BLOOD PRESSURE FLUCTUATION 848 0.0353
335 PRESYNCOPE 857 0.0352
336 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1690 0.0351
337 PNEUMONIA ASPIRATION 876 0.0350
338 DECUBITUS ULCER 285 0.0349
339 HAEMODYNAMIC INSTABILITY 266 0.0349
340 HYPOVOLAEMIA 204 0.0348
341 BACK DISORDER 565 0.0347
342 SKIN ATROPHY 199 0.0345
343 INTERSTITIAL LUNG DISEASE 1660 0.0342
344 LUNG DISORDER 1679 0.0342
345 OESOPHAGITIS 373 0.0341
346 BLOOD PRESSURE DECREASED 2258 0.0339
347 HYPOKALAEMIA 1568 0.0339
348 HEART RATE INCREASED 3363 0.0339
349 RIB FRACTURE 698 0.0339
350 HYPOTHYROIDISM 1083 0.0339
351 APHASIA 1021 0.0338
352 CIRCULATORY COLLAPSE 574 0.0337
353 EOSINOPHILIA 590 0.0336
354 RED BLOOD CELL COUNT DECREASED 960 0.0335
355 CLOSTRIDIUM DIFFICILE COLITIS 353 0.0333
356 COVID-19 5795 0.0330
357 TASTE DISORDER 670 0.0330
358 HYPERTHYROIDISM 477 0.0329
359 INGUINAL HERNIA 200 0.0328
360 PEMPHIGOID 248 0.0328
361 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 202 0.0327
362 SPUTUM DISCOLOURED 309 0.0325
363 PRODUCT PRESCRIBING ISSUE 705 0.0323
364 BLOOD PRESSURE SYSTOLIC INCREASED 630 0.0323
365 SINUS BRADYCARDIA 312 0.0322
366 GINGIVAL PAIN 256 0.0321
367 ATRIOVENTRICULAR BLOCK COMPLETE 215 0.0321
368 HEPATIC CYTOLYSIS 409 0.0320
369 BLOOD COUNT ABNORMAL 485 0.0320
370 PULMONARY FIBROSIS 612 0.0319
371 SUDDEN DEATH 337 0.0318
372 LIMB DISCOMFORT 985 0.0318
373 PAROSMIA 240 0.0318
374 PNEUMOTHORAX 503 0.0317
375 BLOOD CREATININE INCREASED 2066 0.0316
376 BLINDNESS 1287 0.0316
377 CELLULITIS 1584 0.0314
378 PERIPHERAL COLDNESS 431 0.0314
379 LACTIC ACIDOSIS 1016 0.0313
380 DIARRHOEA HAEMORRHAGIC 293 0.0313
381 HYPONATRAEMIA 1757 0.0312
382 PNEUMONIA 10076 0.0311
383 RESPIRATORY FAILURE 2265 0.0310
384 OEDEMA 1683 0.0310
385 CORONAVIRUS INFECTION 205 0.0310
386 SPINAL DISORDER 292 0.0308
387 FAECES SOFT 224 0.0308
388 GENERAL PHYSICAL HEALTH DETERIORATION 3555 0.0307
389 RESPIRATION ABNORMAL 211 0.0306
390 DEAFNESS 798 0.0305
391 DERMATITIS CONTACT 348 0.0305
392 SECRETION DISCHARGE 381 0.0304
393 EMPHYSEMA 306 0.0303
394 CHOLESTASIS 582 0.0303
395 BLADDER DISORDER 300 0.0302
396 THROMBOCYTOPENIA 3365 0.0301
397 ASPIRATION 328 0.0299
398 PRODUCT ADMINISTRATION INTERRUPTED 235 0.0299
399 THYROID DISORDER 461 0.0299
400 URINARY TRACT INFECTION 5095 0.0298
401 ANAL INCONTINENCE 268 0.0298
402 ULCER 473 0.0297
403 CORONARY ARTERY DISEASE 898 0.0296
404 DEHYDRATION 3951 0.0296
405 PALLOR 805 0.0296
406 ANGINA UNSTABLE 192 0.0295
407 RHINITIS 237 0.0294
408 ASTHENIA 11049 0.0294
409 LOCALISED INFECTION 709 0.0293
410 POSTOPERATIVE WOUND INFECTION 198 0.0293
411 SEPTIC SHOCK 1273 0.0292
412 TUBULOINTERSTITIAL NEPHRITIS 543 0.0289
413 PRESCRIBED OVERDOSE 560 0.0289
414 DIZZINESS 14423 0.0289
415 MULTIPLE ORGAN DYSFUNCTION SYNDROME 818 0.0288
416 CARDIOMEGALY 355 0.0288
417 TINNITUS 1321 0.0287
418 DEVICE RELATED INFECTION 442 0.0287
419 GASTRITIS 754 0.0286
420 RESPIRATORY TRACT CONGESTION 455 0.0286
421 ELECTROCARDIOGRAM ABNORMAL 224 0.0285
422 HERNIA 551 0.0285
423 POLYURIA 233 0.0284
424 PALPITATIONS 3330 0.0284
425 UPPER-AIRWAY COUGH SYNDROME 234 0.0284
426 CHEST PAIN 5251 0.0283
427 GAIT INABILITY 947 0.0283
428 SKIN ULCER 728 0.0281
429 SKIN DISCOLOURATION 1294 0.0281
430 HYPERTENSIVE CRISIS 313 0.0281
431 EXOSTOSIS 255 0.0279
432 ARTERIAL OCCLUSIVE DISEASE 219 0.0278
433 ANGINA PECTORIS 798 0.0278
434 URINARY RETENTION 928 0.0278
435 MUSCULAR WEAKNESS 3151 0.0277
436 COUGH 7762 0.0277
437 DIVERTICULITIS 766 0.0276
438 FEELING COLD 769 0.0276
439 LIP SWELLING 915 0.0274
440 BLOOD POTASSIUM DECREASED 823 0.0273
441 NOCTURIA 332 0.0273
442 SCIATICA 436 0.0273
443 COGNITIVE DISORDER 1276 0.0273
444 RENAL FAILURE 3628 0.0273
445 CLOSTRIDIUM DIFFICILE INFECTION 596 0.0273
446 SMALL INTESTINAL OBSTRUCTION 334 0.0271
447 ABNORMAL FAECES 222 0.0271
448 WOUND 757 0.0271
449 SURGERY 1587 0.0270
450 BASAL CELL CARCINOMA 421 0.0270
451 DECREASED ACTIVITY 291 0.0269
452 SEPSIS 3004 0.0269
453 GROIN PAIN 236 0.0268
454 THERAPY CHANGE 264 0.0268
455 BLOOD UREA INCREASED 449 0.0268
456 FLANK PAIN 251 0.0268
457 MUSCLE TWITCHING 617 0.0267
458 TACHYCARDIA 2377 0.0267
459 BLOOD ALBUMIN DECREASED 211 0.0266
460 MEDICATION ERROR 1478 0.0266
461 WEIGHT DECREASED 7416 0.0265
462 NEOPLASM 305 0.0265
463 RASH MACULO-PAPULAR 590 0.0265
464 CATARACT 1572 0.0264
465 CARDIOMYOPATHY 390 0.0264
466 MUSCLE STRAIN 228 0.0263
467 ARTHRITIS 2071 0.0263
468 RENAL CYST 209 0.0263
469 HEAVY MENSTRUAL BLEEDING 236 0.0262
470 ACCIDENT 313 0.0262
471 BODY TEMPERATURE DECREASED 258 0.0262
472 HEPATOCELLULAR INJURY 371 0.0261
473 MYASTHENIA GRAVIS 210 0.0260
474 MUSCULOSKELETAL CHEST PAIN 402 0.0259
475 DECREASED APPETITE 6032 0.0259
476 TACHYPNOEA 353 0.0259
477 PLASMA CELL MYELOMA 1004 0.0257
478 PLATELET COUNT INCREASED 335 0.0257
479 BLOOD POTASSIUM INCREASED 417 0.0257
480 SHOCK 590 0.0256
481 HEAD DISCOMFORT 454 0.0256
482 PNEUMONIA BACTERIAL 235 0.0256
483 PLATELET COUNT DECREASED 2725 0.0255
484 CHEST DISCOMFORT 2618 0.0255
485 HALLUCINATION 1925 0.0255
486 JOINT INJURY 545 0.0255
487 LIGAMENT SPRAIN 252 0.0255
488 VENTRICULAR EXTRASYSTOLES 264 0.0254
489 GENERALISED OEDEMA 314 0.0253
490 MYOCARDIAL INFARCTION 4421 0.0253
491 CYSTITIS 806 0.0253
492 INTERVERTEBRAL DISC DEGENERATION 234 0.0253
493 RESPIRATORY SYNCYTIAL VIRUS INFECTION 220 0.0252
494 BEDRIDDEN 332 0.0252
495 GASTROOESOPHAGEAL REFLUX DISEASE 2033 0.0252
496 TOOTH FRACTURE 278 0.0252
497 CHOLECYSTITIS 300 0.0252
498 SPINAL COMPRESSION FRACTURE 208 0.0251
499 PULMONARY CONGESTION 330 0.0250
500 SPINAL FRACTURE 501 0.0250
501 MUSCULOSKELETAL DISCOMFORT 430 0.0250
502 PAIN IN EXTREMITY 7338 0.0249
503 SENSATION OF FOREIGN BODY 209 0.0248
504 RASH PAPULAR 555 0.0247
505 DYSURIA 909 0.0247
506 BACK PAIN 5732 0.0246
507 BLOOD SODIUM DECREASED 464 0.0246
508 CONFUSIONAL STATE 3974 0.0246
509 CORONARY ARTERY OCCLUSION 337 0.0246
510 DIARRHOEA 15861 0.0245
511 FATIGUE 19100 0.0245
512 LOWER LIMB FRACTURE 470 0.0244
513 TOOTH EXTRACTION 303 0.0243
514 PULMONARY MASS 362 0.0243
515 UPPER LIMB FRACTURE 484 0.0243
516 TOXIC SKIN ERUPTION 244 0.0242
517 DYSPHONIA 1416 0.0242
518 DYSARTHRIA 911 0.0242
519 NEPHROLITHIASIS 1110 0.0242
520 NEUROPATHY PERIPHERAL 2301 0.0242
521 VERTIGO 1472 0.0241
522 WOUND INFECTION 264 0.0241
523 BLINDNESS UNILATERAL 339 0.0240
524 ATELECTASIS 232 0.0240
525 PRODUCT DOSE OMISSION 1566 0.0240
526 SCRATCH 253 0.0240
527 SCAB 273 0.0239
528 RESPIRATORY RATE INCREASED 211 0.0237
529 THERAPY INTERRUPTED 1697 0.0237
530 ASCITES 698 0.0237
531 POST PROCEDURAL INFECTION 193 0.0237
532 PNEUMONITIS 645 0.0237
533 RASH PRURITIC 1282 0.0236
534 PRODUCT ADMINISTRATION ERROR 476 0.0235
535 CONSTIPATION 5122 0.0235
536 PARALYSIS 336 0.0234
537 HYPERTENSION 4966 0.0234
538 BALANCE DISORDER 2019 0.0233
539 URINARY INCONTINENCE 690 0.0233
540 RASH MACULAR 813 0.0232
541 PRODUCT DISPENSING ERROR 506 0.0232
542 FREQUENT BOWEL MOVEMENTS 627 0.0232
543 INCONTINENCE 245 0.0232
544 ADRENAL INSUFFICIENCY 281 0.0231
545 OFF LABEL USE 20258 0.0231
546 KNEE ARTHROPLASTY 486 0.0231
547 AGRANULOCYTOSIS 429 0.0231
548 ABDOMINAL DISCOMFORT 3867 0.0230
549 BLOOD PRESSURE INCREASED 3524 0.0230
550 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 777 0.0230
551 FIBROMYALGIA 559 0.0230
552 LEUKOCYTOSIS 416 0.0230
553 MEMORY IMPAIRMENT 3156 0.0229
554 GALLBLADDER DISORDER 410 0.0229
555 RENAL PAIN 243 0.0229
556 AGEUSIA 571 0.0229
557 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1626 0.0228
558 VISUAL IMPAIRMENT 2831 0.0228
559 LOSS OF CONSCIOUSNESS 2923 0.0228
560 PANCYTOPENIA 1274 0.0228
561 BRONCHITIS 1687 0.0228
562 SINUS DISORDER 451 0.0228
563 DELIRIUM 788 0.0227
564 DRUG LEVEL INCREASED 375 0.0226
565 TOOTH INFECTION 298 0.0226
566 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 232 0.0226
567 URINE OUTPUT DECREASED 197 0.0225
568 PAIN OF SKIN 606 0.0225
569 OSTEOARTHRITIS 953 0.0225
570 CARDIAC ARREST 1853 0.0224
571 BACTERAEMIA 266 0.0224
572 AMNESIA 1457 0.0224
573 ENCEPHALOPATHY 549 0.0223
574 PROSTATIC SPECIFIC ANTIGEN INCREASED 308 0.0223
575 BACK INJURY 243 0.0223
576 DEVICE OCCLUSION 314 0.0223
577 PRODUCT DOSE OMISSION IN ERROR 631 0.0223
578 RESPIRATORY TRACT INFECTION 580 0.0222
579 END STAGE RENAL DISEASE 406 0.0222
580 BRAIN FOG 348 0.0222
581 GAMMA-GLUTAMYLTRANSFERASE INCREASED 492 0.0222
582 ELECTROCARDIOGRAM QT PROLONGED 797 0.0221
583 EYE DISORDER 728 0.0221
584 NERVE COMPRESSION 204 0.0221
585 HEPATIC CIRRHOSIS 415 0.0221
586 MALNUTRITION 247 0.0221
587 MYOCARDIAL ISCHAEMIA 251 0.0220
588 EYE PRURITUS 741 0.0220
589 HYPOCALCAEMIA 417 0.0220
590 CANDIDA INFECTION 372 0.0220
591 PRODUCT PACKAGING ISSUE 209 0.0220
592 POLLAKIURIA 917 0.0220
593 JAUNDICE 591 0.0219
594 FEEDING DISORDER 445 0.0219
595 COMPLICATION ASSOCIATED WITH DEVICE 318 0.0219
596 MICTURITION URGENCY 250 0.0219
597 SQUAMOUS CELL CARCINOMA 206 0.0219
598 CHRONIC KIDNEY DISEASE 1661 0.0218
599 ANKLE FRACTURE 338 0.0218
600 SUPRAVENTRICULAR TACHYCARDIA 209 0.0218
601 COLITIS 825 0.0217
602 KNEE OPERATION 214 0.0217
603 DRY THROAT 221 0.0217
604 TOOTH ABSCESS 221 0.0217
605 ASTHMA 2452 0.0217
606 HYPERLIPIDAEMIA 259 0.0217
607 RETCHING 462 0.0216
608 SINUS CONGESTION 292 0.0216
609 FLATULENCE 1220 0.0215
610 NASAL CONGESTION 1264 0.0215
611 MASS 300 0.0214
612 LEUKAEMIA 202 0.0214
613 UNRESPONSIVE TO STIMULI 552 0.0214
614 HYPERSOMNIA 613 0.0214
615 FEMUR FRACTURE 662 0.0214
616 LUNG NEOPLASM MALIGNANT 878 0.0213
617 BRAIN OEDEMA 269 0.0213
618 GAIT DISTURBANCE 4049 0.0211
619 LIVER FUNCTION TEST ABNORMAL 615 0.0211
620 SWELLING 1976 0.0211
621 PRODUCT DISTRIBUTION ISSUE 195 0.0210
622 HYPOKINESIA 305 0.0210
623 DRUG-INDUCED LIVER INJURY 659 0.0210
624 ACCIDENTAL OVERDOSE 768 0.0210
625 BRAIN INJURY 210 0.0209
626 WRIST FRACTURE 251 0.0209
627 ABDOMINAL PAIN UPPER 4311 0.0209
628 RESPIRATORY DISTRESS 577 0.0209
629 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1487 0.0209
630 ILLNESS 2146 0.0208
631 DERMATITIS ALLERGIC 262 0.0208
632 GLAUCOMA 401 0.0208
633 JOINT SWELLING 2513 0.0208
634 HIP ARTHROPLASTY 318 0.0207
635 ILEUS 258 0.0207
636 NECK PAIN 1160 0.0207
637 MUSCULOSKELETAL PAIN 1086 0.0207
638 ANGIOEDEMA 917 0.0207
639 POST PROCEDURAL COMPLICATION 397 0.0207
640 SARS-COV-2 TEST POSITIVE 273 0.0207
641 HYPOTHERMIA 209 0.0206
642 MALAISE 9047 0.0206
643 POOR VENOUS ACCESS 213 0.0206
644 SPINAL PAIN 241 0.0205
645 DYSPHAGIA 1952 0.0205
646 ABDOMINAL DISTENSION 2132 0.0204
647 SKIN CANCER 439 0.0204
648 SKIN DISORDER 680 0.0204
649 DYSPEPSIA 1997 0.0203
650 VENTRICULAR FIBRILLATION 225 0.0202
651 KIDNEY INFECTION 397 0.0202
652 SPEECH DISORDER 1058 0.0202
653 HEADACHE 12658 0.0202
654 CARDIO-RESPIRATORY ARREST 842 0.0201
655 C-REACTIVE PROTEIN INCREASED 730 0.0200
656 HALLUCINATION, VISUAL 423 0.0200
657 PHARYNGEAL SWELLING 196 0.0200
658 HEPATIC FAILURE 602 0.0199
659 OBESITY 318 0.0199
660 MENTAL STATUS CHANGES 554 0.0199
661 LETHARGY 1142 0.0198
662 RHINORRHOEA 1282 0.0198
663 DISSEMINATED INTRAVASCULAR COAGULATION 279 0.0198
664 IMPAIRED HEALING 650 0.0198
665 SKIN LESION 543 0.0198
666 FRACTURE 374 0.0197
667 LIVER FUNCTION TEST INCREASED 424 0.0197
668 IMPAIRED QUALITY OF LIFE 283 0.0197
669 COMA 936 0.0196
670 RESTLESS LEGS SYNDROME 357 0.0196
671 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 505 0.0196
672 LABORATORY TEST ABNORMAL 578 0.0196
673 GASTROINTESTINAL DISORDER 1754 0.0196
674 TOOTHACHE 354 0.0195
675 POOR QUALITY SLEEP 420 0.0195
676 ACUTE RESPIRATORY DISTRESS SYNDROME 345 0.0195
677 ARTHRALGIA 8092 0.0194
678 DISTURBANCE IN ATTENTION 1048 0.0194
679 ALTERED STATE OF CONSCIOUSNESS 420 0.0194
680 GASTRIC DISORDER 665 0.0194
681 ROTATOR CUFF SYNDROME 248 0.0193
682 TRANSAMINASES INCREASED 429 0.0193
683 ORAL PAIN 431 0.0192
684 OSTEOPOROSIS 791 0.0192
685 ALOPECIA 3774 0.0192
686 SWOLLEN TONGUE 597 0.0191
687 HYPOPHAGIA 487 0.0190
688 NEURALGIA 463 0.0190
689 DIABETES MELLITUS 1445 0.0189
690 ACUTE HEPATIC FAILURE 259 0.0189
691 MOTOR DYSFUNCTION 193 0.0189
692 INTENTIONAL PRODUCT MISUSE 1656 0.0189
693 SKIN INFECTION 211 0.0188
694 INTESTINAL OBSTRUCTION 708 0.0188
695 METASTASES TO LIVER 330 0.0188
696 PANCREATITIS ACUTE 422 0.0188
697 APHONIA 262 0.0188
698 INSURANCE ISSUE 287 0.0187
699 DRUG ERUPTION 332 0.0187
700 JOINT DISLOCATION 198 0.0187
701 HYPERBILIRUBINAEMIA 194 0.0187
702 CYANOSIS 294 0.0187
703 FOOT FRACTURE 354 0.0187
704 PRODUCT DOSE OMISSION ISSUE 5485 0.0186
705 NASOPHARYNGITIS 3436 0.0186
706 DRY MOUTH 1512 0.0186
707 SPLENOMEGALY 218 0.0186
708 PRODUCT USE COMPLAINT 293 0.0186
709 BLOOD CALCIUM DECREASED 209 0.0186
710 EATING DISORDER 395 0.0185
711 DISORIENTATION 735 0.0185
712 PRURITUS 7122 0.0185
713 MYALGIA 3149 0.0185
714 ROAD TRAFFIC ACCIDENT 773 0.0185
715 WHITE BLOOD CELL COUNT DECREASED 1997 0.0184
716 RESPIRATORY DISORDER 551 0.0184
717 HEPATITIS 470 0.0184
718 UPPER RESPIRATORY TRACT INFECTION 846 0.0183
719 INFLUENZA 2039 0.0183
720 MOUTH ULCERATION 385 0.0183
721 THERAPY NON-RESPONDER 821 0.0182
722 OCULAR DISCOMFORT 205 0.0182
723 DIALYSIS 258 0.0182
724 DYSSTASIA 530 0.0181
725 ABDOMINAL PAIN 4196 0.0180
726 WEIGHT INCREASED 4039 0.0180
727 DEPRESSED LEVEL OF CONSCIOUSNESS 713 0.0180
728 HYPOAESTHESIA 2697 0.0180
729 GASTROENTERITIS VIRAL 325 0.0180
730 PRODUCT USE ISSUE 3377 0.0180
731 MUSCLE SPASMS 3297 0.0179
732 BURNING SENSATION 1252 0.0178
733 FEELING ABNORMAL 4277 0.0178
734 METABOLIC ACIDOSIS 570 0.0178
735 NAUSEA 14098 0.0178
736 STAPHYLOCOCCAL INFECTION 586 0.0177
737 ADVERSE DRUG REACTION 1595 0.0177
738 SPINAL OPERATION 218 0.0177
739 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3182 0.0176
740 RASH 7689 0.0176
741 BACTERIAL INFECTION 329 0.0176
742 LOWER RESPIRATORY TRACT INFECTION 801 0.0176
743 CYTOKINE RELEASE SYNDROME 353 0.0176
744 RED BLOOD CELL SEDIMENTATION RATE INCREASED 194 0.0175
745 CYTOPENIA 214 0.0175
746 BLISTER 977 0.0174
747 BLOOD ALKALINE PHOSPHATASE INCREASED 430 0.0173
748 CONDITION AGGRAVATED 5264 0.0173
749 TENDON RUPTURE 213 0.0172
750 OROPHARYNGEAL PAIN 1597 0.0172
751 METASTASES TO BONE 283 0.0172
752 PARAESTHESIA 2709 0.0172
753 GASTROENTERITIS 251 0.0172
754 DENTAL CARIES 190 0.0172
755 THROAT IRRITATION 768 0.0171
756 BLOOD BILIRUBIN INCREASED 462 0.0171
757 HYPERGLYCAEMIA 623 0.0171
758 SLEEP DISORDER 1205 0.0171
759 INTENTIONAL DOSE OMISSION 486 0.0170
760 INCORRECT DOSE ADMINISTERED 3887 0.0170
761 INSOMNIA 4526 0.0170
762 EYE PAIN 955 0.0169
763 EXTRA DOSE ADMINISTERED 685 0.0169
764 METASTASES TO CENTRAL NERVOUS SYSTEM 218 0.0169
765 BURSITIS 205 0.0169
766 MOBILITY DECREASED 1211 0.0168
767 RHABDOMYOLYSIS 702 0.0168
768 POLYNEUROPATHY 201 0.0168
769 VOMITING 7885 0.0168
770 HYPERHIDROSIS 2158 0.0167
771 OSTEOMYELITIS 303 0.0167
772 HYPERCALCAEMIA 206 0.0167
773 MIGRAINE 1591 0.0166
774 STOMATITIS 1006 0.0166
775 MYOCARDITIS 190 0.0166
776 LIVER DISORDER 729 0.0164
777 UNDERDOSE 1192 0.0163
778 HOT FLUSH 1230 0.0163
779 DISABILITY 322 0.0163
780 THERAPY CESSATION 835 0.0162
781 CHOKING 317 0.0162
782 APATHY 237 0.0162
783 MYELODYSPLASTIC SYNDROME 235 0.0162
784 HYPOGLYCAEMIA 783 0.0161
785 CHOLELITHIASIS 529 0.0161
786 ERUCTATION 311 0.0161
787 PRODUCT USE IN UNAPPROVED INDICATION 3978 0.0160
788 PYREXIA 5546 0.0160
789 BONE DISORDER 291 0.0160
790 SNEEZING 358 0.0159
791 PHOTOSENSITIVITY REACTION 263 0.0159
792 INFECTION 2297 0.0159
793 HERPES ZOSTER 910 0.0158
794 FEBRILE NEUTROPENIA 1046 0.0158
795 COLD SWEAT 276 0.0156
796 DIABETES MELLITUS INADEQUATE CONTROL 277 0.0156
797 NIGHT SWEATS 503 0.0156
798 DELUSION 242 0.0156
799 BONE PAIN 912 0.0156
800 CYST 193 0.0155
801 PRODUCT PHYSICAL ISSUE 313 0.0155
802 ABDOMINAL PAIN LOWER 391 0.0154
803 SOMNOLENCE 3110 0.0154
804 MUSCLE TIGHTNESS 250 0.0154
805 WHITE BLOOD CELL COUNT INCREASED 590 0.0154
806 BRONCHOSPASM 219 0.0153
807 SINUSITIS 1561 0.0152
808 RASH ERYTHEMATOUS 728 0.0152
809 SWELLING FACE 988 0.0152
810 NEOPLASM PROGRESSION 526 0.0151
811 CARDIOVASCULAR DISORDER 383 0.0151
812 TREMOR 2499 0.0150
813 INFLAMMATION 774 0.0150
814 DRUG DOSE OMISSION 2477 0.0150
815 MOVEMENT DISORDER 481 0.0150
816 ORAL CANDIDIASIS 197 0.0149
817 NEUTROPENIA 2029 0.0149
818 FUNGAL INFECTION 497 0.0149
819 PARAESTHESIA ORAL 215 0.0149
820 MUSCULOSKELETAL DISORDER 283 0.0149
821 DRUG INTOLERANCE 1435 0.0148
822 SYSTEMIC LUPUS ERYTHEMATOSUS 525 0.0148
823 HEPATIC ENZYME INCREASED 1007 0.0148
824 LACRIMATION INCREASED 444 0.0147
825 LYMPHOMA 227 0.0147
826 OCULAR HYPERAEMIA 696 0.0147
827 EPILEPSY 448 0.0146
828 JOINT STIFFNESS 384 0.0146
829 DYSGEUSIA 1084 0.0146
830 HYPOAESTHESIA ORAL 219 0.0145
831 PAIN 8903 0.0145
832 MALIGNANT NEOPLASM PROGRESSION 1483 0.0145
833 VISION BLURRED 1981 0.0144
834 VIRAL INFECTION 480 0.0144
835 IMMUNODEFICIENCY 214 0.0143
836 ECZEMA 750 0.0143
837 NIGHTMARE 494 0.0143
838 SENSORY DISTURBANCE 229 0.0143
839 MUSCULOSKELETAL STIFFNESS 1250 0.0143
840 CHILLS 1671 0.0142
841 HEPATIC STEATOSIS 265 0.0142
842 LUNG INFECTION 221 0.0142
843 PRODUCT AVAILABILITY ISSUE 323 0.0142
844 BODY TEMPERATURE INCREASED 289 0.0142
845 SEIZURE 1631 0.0141
846 DISCOMFORT 859 0.0141
847 EAR PAIN 273 0.0140
848 RASH GENERALISED 359 0.0138
849 THIRST 247 0.0138
850 LEUKOPENIA 691 0.0138
851 ABSCESS 220 0.0138
852 NEUTROPHIL COUNT DECREASED 561 0.0138
853 ANXIETY 3858 0.0135
854 GLYCOSYLATED HAEMOGLOBIN INCREASED 340 0.0135
855 PRURITUS GENERALISED 291 0.0134
856 INTERVERTEBRAL DISC PROTRUSION 294 0.0134
857 DISEASE PROGRESSION 1572 0.0133
858 DRY SKIN 1767 0.0132
859 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2659 0.0131
860 RESTLESSNESS 480 0.0131
861 INCORRECT PRODUCT ADMINISTRATION DURATION 284 0.0131
862 NERVOUSNESS 684 0.0131
863 EYE SWELLING 485 0.0130
864 MENTAL IMPAIRMENT 316 0.0130
865 HEPATIC FUNCTION ABNORMAL 485 0.0130
866 LIVER INJURY 317 0.0129
867 SKIN FISSURES 252 0.0129
868 BLOOD LACTATE DEHYDROGENASE INCREASED 204 0.0129
869 STEVENS-JOHNSON SYNDROME 286 0.0129
870 LYMPHADENOPATHY 454 0.0128
871 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 298 0.0128
872 ALANINE AMINOTRANSFERASE INCREASED 781 0.0127
873 FEELING HOT 777 0.0127
874 SKIN EXFOLIATION 1068 0.0126
875 MIDDLE INSOMNIA 236 0.0126
876 PRODUCT STORAGE ERROR 1104 0.0126
877 COLITIS ULCERATIVE 563 0.0126
878 BLOOD GLUCOSE ABNORMAL 232 0.0125
879 UNEVALUABLE EVENT 948 0.0125
880 DRY EYE 625 0.0125
881 ASPARTATE AMINOTRANSFERASE INCREASED 663 0.0125
882 TENDONITIS 193 0.0125
883 LYMPHOCYTE COUNT DECREASED 219 0.0124
884 IRRITABLE BOWEL SYNDROME 265 0.0123
885 PHOTOPHOBIA 232 0.0123
886 DEPRESSED MOOD 643 0.0122
887 TYPE 2 DIABETES MELLITUS 404 0.0120
888 PANCREATITIS 634 0.0120
889 ERYTHEMA 2455 0.0119
890 FLUSHING 1212 0.0119
891 THERAPEUTIC RESPONSE UNEXPECTED 532 0.0118
892 PROCEDURAL PAIN 328 0.0118
893 ERECTILE DYSFUNCTION 303 0.0118
894 DRUG ADMINISTRATION ERROR 362 0.0118
895 URTICARIA 1974 0.0118
896 RENAL INJURY 350 0.0118
897 FACE OEDEMA 198 0.0117
898 HYPERSENSITIVITY 2146 0.0115
899 IMPAIRED WORK ABILITY 247 0.0115
900 BLOOD CREATINE PHOSPHOKINASE INCREASED 330 0.0115
901 EAR INFECTION 305 0.0114
902 INJURY 803 0.0114
903 INTENTIONAL OVERDOSE 732 0.0114
904 DEPRESSION 2585 0.0114
905 TREATMENT FAILURE 935 0.0113
906 PANCREATIC CARCINOMA 325 0.0112
907 THINKING ABNORMAL 209 0.0112
908 BLOOD GLUCOSE INCREASED 2055 0.0109
909 FEELING JITTERY 206 0.0108
910 ORAL HERPES 211 0.0108
911 DYSKINESIA 439 0.0108
912 EXPIRED PRODUCT ADMINISTERED 359 0.0108
913 EYE IRRITATION 617 0.0107
914 BLOOD CHOLESTEROL INCREASED 495 0.0106
915 PROTEINURIA 200 0.0105
916 DEVICE DISLOCATION 455 0.0105
917 RESPIRATORY ARREST 284 0.0103
918 BLOOD GLUCOSE DECREASED 492 0.0102
919 DIABETIC KETOACIDOSIS 244 0.0101
920 TOXICITY TO VARIOUS AGENTS 1705 0.0101
921 MUCOSAL INFLAMMATION 263 0.0100
922 SUICIDE ATTEMPT 604 0.0100
923 INCREASED APPETITE 190 0.0099
924 DERMATITIS 207 0.0099
925 GLOSSODYNIA 221 0.0099
926 PANIC ATTACK 353 0.0097
927 ANAPHYLACTIC REACTION 535 0.0097
928 AGITATION 710 0.0097
929 FEAR 260 0.0097
930 INFUSION RELATED REACTION 631 0.0095
931 DISEASE RECURRENCE 445 0.0093
932 THROAT TIGHTNESS 248 0.0092
933 DRUG INEFFECTIVE 11920 0.0090
934 NERVOUS SYSTEM DISORDER 281 0.0090
935 ABASIA 221 0.0089
936 INFLUENZA LIKE ILLNESS 719 0.0087
937 ILL-DEFINED DISORDER 525 0.0086
938 MENTAL DISORDER 375 0.0086
939 HEPATOTOXICITY 190 0.0085
940 NEEDLE ISSUE 248 0.0085
941 RHEUMATOID ARTHRITIS 965 0.0085
942 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 464 0.0084
943 WRONG TECHNIQUE IN DRUG USAGE PROCESS 307 0.0084
944 ABNORMAL DREAMS 232 0.0084
945 THERAPEUTIC PRODUCT EFFECT DECREASED 375 0.0084
946 PSYCHOTIC DISORDER 241 0.0082
947 GASTRIC CANCER 206 0.0081
948 VISUAL ACUITY REDUCED 264 0.0079
949 THERAPEUTIC RESPONSE SHORTENED 248 0.0075
950 INJECTION SITE HAEMORRHAGE 595 0.0074
951 ANAPHYLACTIC SHOCK 192 0.0074
952 COMPLETED SUICIDE 607 0.0073
953 INJECTION SITE BRUISING 571 0.0072
954 OVERDOSE 1540 0.0071
955 MOOD ALTERED 193 0.0071
956 PROSTATE CANCER 569 0.0071
957 PSORIATIC ARTHROPATHY 284 0.0070
958 DEVICE LEAKAGE 300 0.0069
959 DEVICE MALFUNCTION 469 0.0067
960 NO ADVERSE EVENT 1189 0.0066
961 EMOTIONAL DISORDER 200 0.0065
962 SKIN IRRITATION 297 0.0065
963 ABNORMAL BEHAVIOUR 254 0.0064
964 INJECTION SITE MASS 237 0.0064
965 SUICIDAL IDEATION 583 0.0064
966 DEVICE ISSUE 565 0.0063
967 PRODUCT SUBSTITUTION ISSUE 361 0.0063
968 BLADDER CANCER 367 0.0062
969 RENAL FAILURE ACUTE 262 0.0062
970 BREAST CANCER 561 0.0060
971 PSORIASIS 766 0.0059
972 AGGRESSION 287 0.0057
973 IRRITABILITY 328 0.0054
974 MYELOSUPPRESSION 196 0.0054
975 ACNE 406 0.0053
976 THERAPEUTIC RESPONSE DECREASED 295 0.0049
977 PRODUCT QUALITY ISSUE 634 0.0047
978 MULTIPLE SCLEROSIS 221 0.0046
979 INJECTION SITE PRURITUS 284 0.0042
980 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 198 0.0042
981 INJECTION SITE PAIN 1262 0.0041
982 INJECTION SITE SWELLING 296 0.0039
983 MATERNAL EXPOSURE DURING PREGNANCY 333 0.0037
984 DERMATITIS ATOPIC 197 0.0037
985 INJECTION SITE ERYTHEMA 447 0.0036
986 ACCIDENTAL EXPOSURE TO PRODUCT 364 0.0035
987 SKIN BURNING SENSATION 227 0.0032
988 EMOTIONAL DISTRESS 364 0.0030
989 DRUG ABUSE 246 0.0030
990 MULTIPLE SCLEROSIS RELAPSE 202 0.0029
991 DEVICE DIFFICULT TO USE 192 0.0029
992 FOETAL EXPOSURE DURING PREGNANCY 192 0.0024